Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus Seminar 3/3

Stephen J. Greene*, Johann Bauersachs, Jasper J. Brugts, Justin A. Ezekowitz, Gerasimos Filippatos, Finn Gustafsson, Carolyn S.P. Lam, Lars H. Lund, Robert J. Mentz, Burkert Pieske, Piotr Ponikowski, Michele Senni, Natalie Skopicki, Adriaan A. Voors, Faiez Zannad, Shelley Zieroth, Javed Butler*

*Corresponding author voor dit werk

Onderzoeksoutputpeer review

14 Citaten (Scopus)
38 Downloads (Pure)


Despite worsening heart failure (HF) being extremely common, expensive, and associated with substantial risk of death, there remain no dedicated clinical practice guidelines for the specific management of these patients. The lack of a management guideline is despite a rapidly evolving evidence-base, as a number of recent clinical trials have demonstrated multiple therapies to be safe and efficacious in this high-risk population. Herein, we propose a framework for treating worsening HF with reduced ejection fraction with the sense of urgency it deserves. This includes treating congestion; managing precipitants; and establishing a foundation of rapid-sequence, simultaneous, and/or in-hospital initiation of quadruple medical therapy for HF with reduced ejection fraction, with the top priority being at least low doses of all 4 medications. Moreover, to maximally reduce residual clinical risk, we further propose consideration of upfront simultaneous use of vericiguat (ie, quintuple medical therapy) and administration of intravenous iron for those who are iron deficient.

Originele taal-2English
Pagina's (van-tot)559-571
Aantal pagina's13
TijdschriftJournal of the American College of Cardiology
Nummer van het tijdschrift6
StatusPublished - 8-aug.-2023


Duik in de onderzoeksthema's van 'Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus Seminar 3/3'. Samen vormen ze een unieke vingerafdruk.

Citeer dit